로딩 중…
지수 로딩 중…
Sugentech Inc.
253840· KOSDAQ· Health Care· Health Care Equipment & Services
₩4,570-1.51%
2026-06-19
Price Chart
Sugentech Inc.-42.88%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 76.52B KRW |
| Revenue | 9.87B KRW |
| Net Income | -12.37B KRW |
| Total Assets | 93.72B KRW |
| Net Assets | 72.28B KRW |
| Employees | 152 |
| Value | |
| P/B | 1.06x |
| P/S | 7.75x |
| Profitability | |
| ROE | -17.11% |
| ROA | -13.20% |
| Op. Margin | -197.83% |
| Revenue Growth | 24.18% |
| Financial Health | |
| Debt Ratio | 129.67% |
| Total Debt | 11.23B KRW |
| Cash | 20.16B KRW |
| Current Ratio | 10.82x |
| Performance | |
| 1Y Return | -42.88% |
| 1M Return | -40.10% |
| From 52W High | -48.94% |
| 1Y MDD | -48.86% |
| Trading | |
| Volume | 219,703 shares |
| Foreign Own. | 1.14% |
| Per Share | |
| EPS | -1,461 KRW |
| BPS | 4,713 KRW |
Company Info
Established in 2011, the company achieved KONEX listing in 2016 and KOSDAQ transfer listing in 2019, with its main business being the research and development, manufacturing, and sales of in vitro diagnostic medical devices. It commercializes multiple immunoassay blots based on BIO/NANO/IT/A.I fusion technology and offers TRF and fluorescence-based quantitative analysis products for point-of-care diagnostics. In digital healthcare, Sugentech launched the nation's sole digital device for female hormone diagnosis, expanding into the health & beauty category to evolve into a comprehensive wellness platform. Sugentech is headquartered in Yuseong-gu, Daejeon Metropolitan City.